title: [New transparency between physicians and the pharmaceutical industry].
abstract: The long-lasting trusting partnership between physicians and the pharmaceutical industry with respect to experience from applied research of medications and vocational training, was severely tested by campaign-like dissemination of collective accusations of corruption. Instead of standing by their responsibility to financing clinical research and vocational training of physicians, the health insurance companies in particular claim that physicians are being extensively bribed by the pharmaceutical industry. In order to continuously improve the mutual targets, i.e. the treatment options for patients, both groups have developed transparency regulations.
authors.affiliation: Pressesprecher des Berufsverbandes der Deutschen Urologen e.V., Keitumer Süderstraße 33 c, 25980, Sylt OT Keitum, Deutschland, Dr.W.Buehmann@t-online.de.
authors.forename: W
authors.initials: W
authors.lastname: Bühmann
mesh_terms: D035843:Biomedical Research / Q000941:ethics / Q000331:legislation & jurisprudence*; D030881:Disclosure / Q000941:ethics / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000941:ethics / Q000331:legislation & jurisprudence*; D005858:Germany; D007400:Interprofessional Relations / Q000941:ethics*; D010820:Physicians / Q000941:ethics / Q000331:legislation & jurisprudence*; D012017:Referral and Consultation / Q000941:ethics / Q000331:legislation & jurisprudence*